No abstract available
MeSH terms
-
Antipsychotic Agents / pharmacology
-
Antipsychotic Agents / therapeutic use*
-
Clinical Trials, Phase II as Topic
-
Glycine Plasma Membrane Transport Proteins / antagonists & inhibitors
-
Humans
-
Piperazines / pharmacology
-
Piperazines / therapeutic use*
-
Schizophrenia / drug therapy*
-
Schizophrenia / physiopathology
-
Schizophrenic Psychology
-
Sulfones / pharmacology
-
Sulfones / therapeutic use*
-
Treatment Outcome
Substances
-
(4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl)(5-methanesulfonyl-2-(2,2,2-trifluoro-1-methylethoxy)phenyl)methanone
-
Antipsychotic Agents
-
Glycine Plasma Membrane Transport Proteins
-
Piperazines
-
SLC6A9 protein, human
-
Sulfones